Ronald B. Herberman

35.2k total citations · 7 hit papers
518 papers, 28.1k citations indexed

About

Ronald B. Herberman is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ronald B. Herberman has authored 518 papers receiving a total of 28.1k indexed citations (citations by other indexed papers that have themselves been cited), including 370 papers in Immunology, 126 papers in Oncology and 99 papers in Molecular Biology. Recurrent topics in Ronald B. Herberman's work include Immune Cell Function and Interaction (243 papers), Immunotherapy and Immune Responses (117 papers) and T-cell and B-cell Immunology (90 papers). Ronald B. Herberman is often cited by papers focused on Immune Cell Function and Interaction (243 papers), Immunotherapy and Immune Responses (117 papers) and T-cell and B-cell Immunology (90 papers). Ronald B. Herberman collaborates with scholars based in United States, Italy and Canada. Ronald B. Herberman's co-authors include Howard T. Holden, John R. Ortaldo, Myrthel E. Nunn, Theresa L. Whiteside, David H. Lavrin, Julie Y. Djeu, Guy D. Bonnard, Holger Kirchner, Nikola L. Vujanović and William H. West and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ronald B. Herberman

509 papers receiving 25.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Killer Cells: Their Roles in Defenses Against Disease

1981 1.1k citations Ronald B. Herberman, John R. Ortaldo profile →
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity

1975 1.1k citations Ronald B. Herberman et al. profile →
Natural Cell-Mediated Immunity

1978 834 citations Ronald B. Herberman, Howard T. Holden profile →
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells

1975 660 citations Ronald B. Herberman, Howard T. Holden et al. profile →
Augmentation of Mouse Natural Killer Cell Activity by Interferon and Interferon Inducers

1979 485 citations Howard T. Holden, Ronald B. Herberman et al. The Journal of Immunology profile →
Natural Killer Cells: Characteristics and Regulation of Activity

1979 444 citations Ronald B. Herberman, H. David Kay et al. profile →
Natural Cytotoxic Reactivity of Human Lymphocytes Against a Myeloid Cell Line: Characterization of Effector Cells

1977 404 citations H. David Kay, Guy D. Bonnard et al. The Journal of Immunology profile →

Peers

Ronald B. Herberman

IMMUN

ONCOL

RNMI

EPIDE

William E. Paul United States

Edgar G. Engleman United States

Hans Wigzell Sweden

Jonathan Sprent United States

Takashi Saito Japan

Abul K. Abbas United States

Dennis A. Carson United States

Marco Baggiolini Switzerland

Raif S. Geha United States

Albert Zlotnik United States

William E. Paul United States

Ronald B. Herberman

30.2k ×1.6

IMMUN

6.1k ×0.9

ONCOL

8.2k ×1.5

3.4k ×1.1

RNMI

3.4k ×1.5

EPIDE

Citations per year, relative to Ronald B. Herberman Ronald B. Herberman (= 1×) peers William E. Paul

Countries citing papers authored by Ronald B. Herberman

Since Specialization

Citations

This map shows the geographic impact of Ronald B. Herberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. Herberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. Herberman more than expected).

Fields of papers citing papers by Ronald B. Herberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. Herberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. Herberman. The network helps show where Ronald B. Herberman may publish in the future.

Co-authorship network of co-authors of Ronald B. Herberman

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald B. Herberman. A scholar is included among the top collaborators of Ronald B. Herberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald B. Herberman. Ronald B. Herberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Weiwei, Wenna Chen, Ronald B. Herberman, et al.. (2013). Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK). Cancer Letters. 344(2). 212–222. 44 indexed citations

Meyskens, Frank L., Gregory A. Curt, Dean E. Brenner, et al.. (2011). Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic. Cancer Prevention Research. 4(3). 311–323. 36 indexed citations

Levina, Vera, Brian M. Nolen, Andrew K. Godwin, et al.. (2009). Biological Significance of Prolactin in Gynecologic Cancers. Cancer Research. 69(12). 5226–5233. 75 indexed citations

Ge, Lisheng, Dejan Baskić, Per Basse, et al.. (2009). Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer. Cancer Epidemiology Biomarkers & Prevention. 18(11). 2913–2922. 18 indexed citations

Levina, Vera, Adele Marrangoni, Tingting Wang, et al.. (2009). Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor–c-kit Autocrine Signaling Loop. Cancer Research. 70(1). 338–346. 124 indexed citations

Janjic, Bratislav, Xiaofei Wang, Julien Fourcade, et al.. (2006). Spontaneous CD4+ T Cell Responses against TRAG-3 in Patients with Melanoma and Breast Cancers. The Journal of Immunology. 177(4). 2717–2727. 15 indexed citations

Glaser, Ronald, David A. Padgett, Monica L. Litsky, et al.. (2004). Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: Implications for chronic fatigue syndrome and cancer. Brain Behavior and Immunity. 19(2). 91–103. 99 indexed citations

Walter, Mark R., Ronald Bordens, Tattanahalli L. Nagabhushan, et al.. (1998). Review of Recent Developments in the Molecular Characterization of Recombinant Alfa Interferons on the 40th Anniversary of the Discovery of Interferon. Cancer Biotherapy and Radiopharmaceuticals. 13(3). 143–154. 29 indexed citations

Levine, Paul H., et al.. (1998). Dysfunction of Natural Killer Activity in a Family with Chronic Fatigue Syndrome. Clinical Immunology and Immunopathology. 88(1). 96–104. 53 indexed citations

10.

Whiteside, Theresa L. & Ronald B. Herberman. (1990). Serum and tissue banks for biological markers.. PubMed. 53. 55–68. 1 indexed citations

11.

Melder, Robert J., Raghavan Balachandran, Charles R. Rinaldo, et al.. (1990). Cytotoxic Activity Against HIV-infected Monocytes by Recombinant Interleukin 2-Activated Natural Killer Cells. AIDS Research and Human Retroviruses. 6(8). 1011–1015. 19 indexed citations

12.

Talmadge, James E., Annette E. Maluish, Margaret S. Collins, et al.. (1984). Immunomodulation and antitumor effects of MVE-2 in mice.. PubMed. 3(6). 634–52. 15 indexed citations

13.

Goldfarb, R H, Tuomo Timonen, & Ronald B. Herberman. (1984). Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.. The Journal of Experimental Medicine. 159(3). 935–951. 29 indexed citations

14.

Jones, C. Michael, Luigi Varesio, Ronald B. Herberman, & Sidney Pestka. (1982). Interferon Activates Macrophages to Produce Plasminogen Activator. Journal of Interferon Research. 2(3). 377–386. 25 indexed citations

15.

Ortaldo, John R., Nicholas P. Lang, Tuomo Timonen, & Ronald B. Herberman. (1981). Augmentation of Human Natural Killer Cell Activity by Interferon: Conditions Required for Boosting and Characteristics of the Effector Cells. Journal of Interferon Research. 1(2). 253–262. 15 indexed citations

16.

Kay, H. David, Guy D. Bonnard, & Ronald B. Herberman. (1979). Evaluation of the Role of IgG Antibodies in Human Natural Cell-Mediated Cytotoxicity Against the Myeloid Cell Line K562. The Journal of Immunology. 122(2). 675–685. 25 indexed citations

17.

Herberman, Ronald B., et al.. (1976). Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2 pt 2). 615–21. 25 indexed citations

18.

Ting, Chou‐Chik, et al.. (1976). Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(1). 244–52. 22 indexed citations

19.

Bonnard, G D, Eric Manders, Darrell A. Campbell, Ronald B. Herberman, & Michael J. Collins. (1976). Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition.. The Journal of Experimental Medicine. 143(1). 187–205. 110 indexed citations

20.

Herberman, Ronald B. & Chandler A. Stetson. (1965). THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON CELLULAR AND SUBCELLULAR MEMBRANES. The Journal of Experimental Medicine. 121(4). 533–549. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact